Real-time magnetic resonance imaging-guided brachytherapy in the treatment of selected patients with clinically localized prostate cancer

Journal of Endourology

Volumn 14, Issue 4, 2000, Pages 367-370

  D'Amico, Anthony V ^a   Cormack, Robert ^a   Kumar, Sanjaya ^b   Tempany, Clare M ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; DOSIMETRY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; TREATMENT OUTCOME;

EID: 0033919397     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2000.14.367     Document Type: Article

References (13)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clinicians 1998;48:6-30.
2. Ragde H, Blasko JC, Grimm PD, Kenny GM, Sylvester JE, Hoak DC, Landin K, Cavanagh W. Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma. Cancer 1997;80:442-453.
3. Wallner K, Roy J, Zelefsky M, Fuks Z, Harrison L. Short term freedom from disease progression after I-125 prostate implantation. Int J Radiat Oncol Biol Phys 1994;30:405-409.
4. Beahrs OH, Henson DE, Mutter RVP. American Joint Committee on Cancer Manual for Staging Cancer, ed 4. Philadelphia: JB Lippincott, 1997.
5. Gleason DF, Veterans Administration Cooperative Urological Research Group. Histologic grading and staging of prostatic carcinoma. In: Tannenbaum M (ed): Urologic Pathology. Philadelphia: Lea & Febiger, 1977, pp 171-187.
6. Oesterling JE, Jacobsen SJ, Klee GG, et al. Free, complexed and total serum prostate specific antigen: The establishment of appropriate reference ranges for their concentrations and ratios. J Urol 1995;154:1090-1095.
7. Schenck JF, Jolesz FA, Roemer PB, et al. Superconducting open configuration MRI system for image-guided therapy. Radiology 1995;195:23.
8. Kaufman L, Arakawa M, Hale J, et al. Accesible magnetic resonance imaging. Magn Reson Q 1989;5:283-297.
9. Jolesz F. Interventional and intraoperative MRI: A general overview of the field. JMRI. 1998;8:3-7.
10. Talcott JA, Reiker P, Propert KJ, et al. Patient reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst 1997;89:1117-1123.
11. Wallner K, Roy J, Harrison L. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 1995;32:465-471.
12. Cormack RA, D'Amico AV, Holupka E, Kooy HM, Powers RE, Svensson G. Real time dosimetry based prostate implant planing system. In: Leavitt DD, Starkschal G (eds): Proceedings of the XII International Conference on the Use of Computers in Radiation Therapy. Salt Lake City: Medical Physics Publishing, 1997, 124-126.
13. Nath R, Anderson LL, Luxton G, Weaver KA, Williamson JF, Meigooni AS. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. Med Phys 1995;22:209-234.